"Gene Products, gag" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.
| Descriptor ID |
D015683
|
| MeSH Number(s) |
D12.776.775.330 D12.776.964.775.350 D12.776.964.970.600.850.350
|
| Concept/Terms |
Gene Products, gag- Gene Products, gag
- gag Polyprotein
- Polyprotein, gag
- gag Polyproteins
- Polyproteins, gag
- gag Protein
- Protein, gag
- Retroviral Antigen gag Protein
- Viral gag Proteins
- Proteins, Viral gag
- gag Proteins, Viral
- Gene Product, gag
- gag Gene Product
- gag Gene Products
- gag Antigens
- Antigens, gag
- gag Viral Proteins
- Proteins, gag Viral
- Viral Proteins, gag
|
Below are MeSH descriptors whose meaning is more general than "Gene Products, gag".
Below are MeSH descriptors whose meaning is more specific than "Gene Products, gag".
This graph shows the total number of publications written about "Gene Products, gag" by people in this website by year, and whether "Gene Products, gag" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Products, gag" by people in Profiles.
-
Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am J Pathol. 2010 Aug; 177(2):777-91.
-
Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005 Mar 01; 174(5):2900-9.
-
HIV-infected lymphocytes regulate fibronectin synthesis by TGF beta 1 secretion. J Immunol. 2004 Mar 01; 172(5):3189-95.
-
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen. J Virol. 2003 Aug; 77(15):8354-65.
-
Semi-allogeneic vaccines for patients with cancer and AIDS. J Immunother. 2002 Jul-Aug; 25(4):334-41.
-
Activation of a cryptic splice donor in human immunodeficiency virus type-1. J Biomed Sci. 1999 Jan; 6(1):45-52.
-
HIV-1 protease regulation: the role of the major homology region and adjacent C-terminal capsid sequences. J Biomed Sci. 1998 Jul-Aug; 5(4):305-8.
-
Regulation of intracellular human immunodeficiency virus type-1 protease activity. Virology. 1998 Apr 25; 244(1):87-96.
-
Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element. Virology. 1996 May 15; 219(2):423-31.
-
Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum. 1991 Oct; 34(10):1336-7.